Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial

Circulation - United States
doi 10.1161/circulationaha.112.130880
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Renal Denervation for Resistant Hypertension—the Symplicity HTN-1 Study

The Lancet
Medicine
2014English

CONGRESS COVERAGE: Renal Sympathetic Denervation for Resistant Hypertension: Symplicity HTN-3 and the Power of Placebo

Open Hypertension Journal
Cardiovascular MedicineCardiology
2014English

Renal Sympathetic Denervation Versus Antiarrhythmic Drugs for Drug-Resistant Hypertension and Symptomatic Atrial Fibrillation (RSDforAF) Trial: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2013English

A Controlled Trial of Renal Denervation for Resistant Hypertension

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2014English

Renal Denervation in the Treatment of Resistant Hypertension: Results of a One-Year Observational Study

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2015English

Meta-Analysis of Randomized Controlled Trials of Renal Denervation in Treatment-Resistant Hypertension

Blood Pressure
Internal MedicineMedicineCardiovascular MedicineCardiology
2015English

Expanding the Targets of Renal Sympathetic Denervation: From Resistant Hypertension to Atrial Fibrillation

Journal of Hypertension- Open Access
2013English

Catheter-Based Renal Sympathetic Denervation – Long-Term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives

Interventional Cardiology Review
Cardiovascular MedicineCardiology
2013English

Cost Effectiveness of Renal Denervation Therapy for the Treatment of Resistant Hypertension in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy